The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma

Uveal melanoma (UM) is the most frequent malignant ocular tumor in adults. While the primary tumor is efficiently treated by surgery and/or radiotherapy, about one third of UM patients develop metastases, for which no effective treatment is currently available. The PKC, MAPK and PI3K/AKT/mTOR signal...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Amirouchene-Angelozzi, Nabil, Frisch-Dit-Leitz, Estelle, Carita, Guillaume, Dahmani, Ahmed, Raymondie, Chloé, Liot, Géraldine, Gentien, David, Némati, Fariba, Decaudin, Didier, Roman-Roman, Sergio, Schoumacher, Marie
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029652/
https://ncbi.nlm.nih.gov/pubmed/26988753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8054
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы